BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 1102620)

  • 1. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
    Jordon RE; Nordby JM; Milstein H
    J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin.
    Provost TT; Tomasi TB
    Clin Exp Immunol; 1974 Oct; 18(2):193-200. PubMed ID: 4619597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor".
    Jordon RE; Heine KG; Tappeiner G; Bushkell LL; Provost TT
    J Clin Invest; 1976 Jun; 57(6):1426-31. PubMed ID: 58871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexistence of bullous pemphigoid and systemic lupus erythematosus.
    Kumar V; Binder WL; Schotland E; Beutner EH; Chorzelski TP
    Arch Dermatol; 1978 Aug; 114(8):1187-90. PubMed ID: 354534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathological findings in herpes gestationis (author's transl)].
    Scherer R; Wolff HH; Braun-Falco O
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1155-60. PubMed ID: 330132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complement system in bullous pemphigoid. VI. C3 fixing activity in the absence of detectable antibody.
    Millns JL; Meurer M; Jordon RE
    Clin Immunol Immunopathol; 1979 Aug; 13(4):475-83. PubMed ID: 385191
    [No Abstract]   [Full Text] [Related]  

  • 8. The complement system in bullous pemphigoid: VII. Fixation of the regulatory protein beta 1H globulin by pemphigoid antibody.
    Lee CW; Jordon RE
    J Invest Dermatol; 1980 Dec; 75(6):465-9. PubMed ID: 6449528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mechanism of antigen-antibody reaction at the basement membrane zone in bullous pemphigoid. The question of interaction of complement factors and bivalent cations (author's transl)].
    Bockendahl H; Remy W; Stüttgen G; Petersen G
    Arch Dermatol Res (1975); 1975 Dec; 254(2):135-42. PubMed ID: 56158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cicatricial pemphigoid of Brunsting-Perry. Immunofluorescent studies.
    Michel B; Bean SF; Chorzelski T; Fedele CF
    Arch Dermatol; 1977 Oct; 113(10):1403-5. PubMed ID: 334084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.
    Jordon RE; Day NK; Sams WM; Good RA
    J Clin Invest; 1973 May; 52(5):1207-14. PubMed ID: 4573354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of urticaria and acute serum sickness with the C1q precipitin test.
    Lieberman P; Rice MC; Mallette JE
    Arch Intern Med; 1977 Apr; 137(4):440-2. PubMed ID: 139855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y; Vernier RL; Fish AJ; Michael AF
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 17. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
    Tappeiner G; Heine KG; Kahl JC; Jordon RE
    Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cicatricial pemphigoid. (Immunofluorescent studies).
    Bean SF
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1977; 84(3 Pt 2):ORL530-3. PubMed ID: 329530
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psoriasis and bullous pemphigoid].
    Bork K
    Hautarzt; 1987 Jun; 38(6):348-51. PubMed ID: 3308771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-fixing intercellular antibodies in a case of cicatricial pemphigoid.
    Kumar V; Yarbrough C; Beutner EH
    Arch Dermatol; 1980 Jul; 116(7):812-4. PubMed ID: 6994660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.